We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Medical Bed Companies Seek Additional Markets

By HospiMedica International staff writers
Posted on 21 Nov 2011
Makers of medical beds used in hospitals, nursing homes, and patients’ homes will see their best growth come from markets outside the United States and Europe. More...
These are the latest finding of Kalorama Information (New York, NY, USA), an independent medical market research firm.

The medical bed market is competitive, and has become increasingly so since the introduction of cost-cutting measures in European countries, new comparative bidding processes, and future device taxes to be introduced in the United States as part of healthcare reform. Although these negative factors are somewhat mitigated by the aging populations in these countries and the expected associated increases in diseases and hospitalizations, the outcome will be small growth rates. As a result, the USD 5.3 billion market for medical beds will see small growth over the next five years in traditionally strong markets, but higher growth can be expected in other countries that are recently beginning to build up their healthcare systems.

This trend will change the way bed manufacturers look at their marketing efforts, and where they locate distributors and sales personnel. Sales outside the US and Europe are projected to grow from 13% to 18% of total worldwide medical bed sales between 2011 and 2016. Africa and the Middle East are among the regions that Kalorama Information sees companies targeting more in the future. India, in particular, holds 20% of the world average number of hospital beds per million population, and an estimated 455,000 additional beds will be required by 2012. China and Brazil have also recently introduced increased health care spending and facilities construction. Companies profiled in the report, such as Hill-Rom (Batesville, IN, USA), ArjoHuntleigh (Lund, Sweden), Stryker, and Invacare (Elyria, OH, USA) lead the market for medical beds, and are expanding into these markets as well as markets in Eastern Europe such as the Czech Republic, Russia, and Romania.

“Medical bed makers selling to Europe have already encountered lower sales due to cost restraints, and changes to the US healthcare system are likely to have the same effect,” said Bruce Carlson, publisher of Kalorama Information. “At the same time, we expect sales of medical beds in the rest of the world to more than double by 2016.”

Related Links:
Kalorama Information
ArjoHuntleigh
Invacare





Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Thoracolumbar & Sacropelvic System
Ennovate TLSP
New
Warming Cabinet
EC1850BL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.